Exploring clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine
Globally, more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People with MASLD and more so with metabolic dysfunction-associated steatohepatitis (MASH) and MASLD-associated ...
Mar 4, 2025
0
0